Charity Registration No. 1023606
Company Registration No. 2806607 (England and Wales)
NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
LEGAL AND ADMINISTRATIVE INFORMATION
Trustees
M Hawes
I Martin
D Okell (Chair to 2 May 2024)
M Roberts (not a director)
W Stothart
S Monteiro
W Duckworth (Chair from 2 May 2024)
R Diaz
J Haskey
(Appointed 27 July 2023)
Chief Executive
M Lanham OBE
Secretary
B Dale
Charity number
1023606
Company number
2806607
Registered office
Woodford Lane West
Winsford
Cheshire
CW7 4EH
Auditors
BWM
Suite 5.1
12 Tithebarn Street
Liverpool
L2 2DT
Bankers
Barclays Bank Plc
21 Dingle Walk
Winsford
Cheshire
CW7 1AG
Nationwide Building Society
5 - 11 St Georges Street
Douglas
Isle of Man
IM99 1AS
Solicitors
Barrow & Cook
5-7 Victoria Square
St Helens
Merseyside
WA10 1HH
NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
CONTENTS
Page
Trustees' report
1 - 5
Statement of trustees' responsibilities
6
Independent auditor's report
7 - 9
Statement of financial activities
10 - 11
Balance sheet
12
Statement of cash flows
13
Notes to the financial statements
14 - 29
NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT)
FOR THE YEAR ENDED 31 MARCH 2024
- 1 -

The trustees present their annual report and financial statements for the year ended 31 March 2024.

The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the charity's memorandum and articles of association (as amended 17 October 2019), the Companies Act 2006 and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)".

Objectives and activities

The NMC is the Centre of Excellence for people affected by neuromuscular conditions.

 

Charitable objects

The objects of the NMC are to promote and provide opportunities for people with a neuromuscular condition to live fuller lives through training, employment and physiotherapy, together with advice and support for themselves and their families and carers.

 

Mission

The NMC's mission is to work together with people affected by muscle diseases, creating an environment where full potential and positive wellbeing are achieved, through employment, training, support and physiotherapy.

 

Aims and activities

The NMC aims to be largely user led and to provide a range of services for people affected by muscle disease. Although service users are predominantly from within a 100 mile radius of Winsford, Cheshire, many attend the Centre from across the UK and Europe. The range of services includes:

 

 

The unique combination of services provided by the charity are offered directly to individuals and their families across the UK. Where practicable, physical management programmes are tailored to the needs of each individual, depending on their type of dystrophy and physical condition, through regular sessions of physiotherapy and hydrotherapy. As a ‘centre of excellence’ in the physical management of muscular dystrophy and related neuromuscular conditions, the charity offers help and advice to other organisations worldwide.

 

The charity has established a well-respected graphic design business, NMC Design+Print, in which the variety of skills and talents of the individuals can be employed, developed and rewarded under both salaried and permitted work arrangements. The NMC provides wheelchair-adapted transport for individuals attending the Centre.

NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
TRUSTEES' REPORT (CONTINUED)(INCLUDING DIRECTORS' REPORT)
FOR THE YEAR ENDED 31 MARCH 2024
- 2 -

NMC strategy for 2024-27

In early 2024 we endorsed our 6 strategic objectives for NMC. These were first developed in 2022 and have now been reviewed. They remain our primary goals;

 

Objective 1

Provide impactful social and academic opportunities for our community

 

Objective 2

Enrich the emotional and physical wellbeing of people affected by neuromuscular conditions

 

Objective 3

Inspire, inform, and enable our community to make an active contribution to society

 

Objective 4

Develop a thorough understanding of people in our community and respond in tailored ways

 

Objective 5

Run an effective and professional organisation with excellent governance with sustainability at the core

 

Objective 6

Increase awareness of MD and NMC and increase our influence

 

Volunteer help

NMC has a strong group of volunteers working in:

 

 

Public Benefit

The charity trustees consider that they have complied with their duty in section 17 of the Charities Act 2011 to

have due regard to public benefit guidance published by the Charity Commission and that the benefits that the

charity provides are not unreasonably restricted.

 

NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
TRUSTEES' REPORT (CONTINUED)(INCLUDING DIRECTORS' REPORT)
FOR THE YEAR ENDED 31 MARCH 2024
- 3 -

Achievements against our goals for 2023-24

 

  1. Following the pandemic and a lot of staff changes, we will give focus to developing and consolidating the new young team members we now have. We will seek to encourage mentoring. We will seek to strengthen the youth/experience balance. Achieved – the team now comprises a highly productive mix of youth, energy, and experience. There are now good mentors and excellent leadership throughout.

  2. Following the death of the pivotal leader of NMC Design+Print in 2022 we will seek to rebuild, restructure, and refocus the social enterprise for a thriving future. Achieved to a large degree. Rebuilding following such a huge loss is not a swift process.

  3. Succession planning for long service senior staff is a key priority in the coming year. Largely Achieved. A key element of this has been the successful recruitment of a new Chief Executive to replace the current job holder who is retiring after 19 years in the role. In addition, we have developed plans for shorter term and for longer term succession for other key posts.

  4. Explore the provision of accessible accommodation near to the NMC. No significant progress on this issue. It remains a goal in our new Strategic Plan for 2024-27.

  5. Continue to develop and exploit the opportunities provided to NMC Design+Print following the investment in the Laser cutter/engraver. There has been substantial progress in this regard. More opportunities are undoubtedly there still to be tapped.

  6. Hold special events and make investments in key personnel to help the NMC community tackle the personal post-pandemic challenges. These include issues of housing, employment, support, physical and emotional health. Achieved

  7. Improve outdoor accessibility onsite. This includes relaying the car park and re-furbishing and extending accessible paths and boardwalks. Car park refurbishment complete. Path improvements still to complete.

  8. Refurbish the two old bathrooms/toilet to provide new facilities that incorporate modern design and maximise opportunities for people to be as independent as possible. The refurbished toilets to also offer a chance for people to see what might be helpful at home. Achieved completely.

  9. Develop a new Fundraising Strategy to reflect changes in society, the marketplace for events, our changed capacity, and the end of our long running Spirit of Christmas fundraising event. Lots of scoping has been undertaken. A new strategy is emerging but not yet completed.

 

Fundraising performance

 

Donors to NMC can be assured that we comply with the regulatory standards for fundraising.  The charity adheres to the Code of Fundraising Practice in all its fundraising activities.  Through this guidance, policies and working practices relating to working with vulnerable supporters, handling complaints and ethical considerations are in place. 

 

NMC does not sub-contract elements of its fundraising activities to marketing agencies and undertakes all its correspondence and contact with donors in-house.   

 

The charity received no fundraising complaints during the year.  Complaints are dealt with in line with our complaints policy, with most serious complaints escalated to our Trustees so they can consider lessons to be learnt. 

 

NMC has safeguarding policies in place to protect vulnerable people.  Our fundraisers (both staff and third party) are familiarised with these to ensure the correct procedures are in place.

NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
TRUSTEES' REPORT (CONTINUED)(INCLUDING DIRECTORS' REPORT)
FOR THE YEAR ENDED 31 MARCH 2024
- 4 -
Financial review

Chester Council but no up to date valuation is available.

equipment.

2023-24.

Reserves policy

NMC recognises the need to build and maintain adequate reserves, to ensure that the charity has a financial buffer proportionate to its normal scale of operations. In doing so, this will reduce the financial risk to the charity and help ensure that its services are sustainable.

 

The policy sets out a goal of staying above the following thresholds:

 

1. A minimum amount of total unrestricted reserves of £500,000

 

2. A minimum amount of net current assets of £260,000 of which cash and marketable investments must not be less than £180,000

 

The overall total is equivalent to approximately 4 months of annual spend and approximately 6 months of annual payroll. The Trustees believe that this is a reasonable and proportionate "buffer" to retain against the risk of unseen problems.

 

The current reserves level is £1,367,002 with free reserves being £602,748, restricted reserves being £11,837 and designated reserves being £40,000.

 

Risk management

A register of risks is maintained and reviewed regularly by the Trustees.

 

The following risks have been identified as the most significant for the charity:

 

Plans for 2024-25

NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
TRUSTEES' REPORT (CONTINUED)(INCLUDING DIRECTORS' REPORT)
FOR THE YEAR ENDED 31 MARCH 2024
- 5 -
Structure, governance and management

The Neuromuscular Centre (NMC) is a registered charity, incorporated as a company limited by guarantee. The charity registration number is 1023606 and the company registration number is 2806607. The NMC has a wholly owned dormant subsidiary, NMC Trading Limited.

The trustees, who are also the directors for the purpose of company law, and who served during the year were:

 

M Hawes
A Jeffs
(Resigned 13 April 2023)
I Martin
D Okell (Chair to 2 May 2024)
M Roberts (not a director)
W Stothart
S Monteiro
W Duckworth (Chair from 2 May 2024)
R Diaz
J Haskey
(Appointed 27 July 2023)

 

Appointment of trustees

The charity appointed its Board of Trustees from 1 April 2012. As vacancies arise new Trustees are appointed.

 

Trustee induction and training

Newly appointed trustees receive comprehensive induction including training on their duties and responsibilities under company and charity law and also an induction into the activities, operational plans and financial performance of the charity.

Organisation

The Board of Trustees is ultimately responsible for the management of the Neuromuscular Centre. The Board will meet quarterly. A Chief Executive, with delegated authority, is appointed by and accountable to the trustees for managing the day-to-day operations of the NMC and the delivery of operational plans.

 

The remuneration arrangements for all staff are reviewed annually by the Chair of Trustees and Chief Executive having benchmarked pay levels in the relevant employment roles and sectors and mindful of changes to the UK cost of living indices. The Trustee Board approve the overall remuneration settlement as part of the annual budget setting.

Auditor

In accordance with the company's articles, a resolution proposing that BWM be reappointed as auditor of the company will be put at a General Meeting.

Disclosure of information to auditor

Each of the trustees has confirmed that there is no information of which they are aware which is relevant to the audit, but of which the auditor is unaware. They have further confirmed that they have taken appropriate steps to identify such relevant information and to establish that the auditor is aware of such information.

Small company provisions

This report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.

 

On behalf of the board of trustees

W Duckworth (Chair)
Trustee
Dated: 22 August 2024
NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
STATEMENT OF TRUSTEES' RESPONSIBILITIES
FOR THE YEAR ENDED 31 MARCH 2024
- 6 -

The trustees, who are also the directors of NeuroMuscular Centre for the purpose of company law, are responsible for preparing the Trustees' Report and the accounts in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

 

Company Law requires the trustees to prepare accounts for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that year.

 

In preparing these accounts, the trustees are required to:

 

- select suitable accounting policies and then apply them consistently;

 

- observe the methods and principles in the Charities SORP;

 

- make judgements and estimates that are reasonable and prudent;

 

- state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the accounts; and

 

- prepare the accounts on the going concern basis unless it is inappropriate to presume that the charity will continue in operation.

 

The trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the accounts comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF NEUROMUSCULAR CENTRE
- 7 -

Opinion

We have audited the financial statements of NeuroMuscular Centre (the ‘charity’) for the year ended 31 March 2024 which comprise the statement of financial activities, the balance sheet, the statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion, the financial statements:

-

give a true and fair view of the state of the charitable company's affairs as at 31 March 2024 and of its incoming resources and application of resources, including its income and expenditure, for the year then ended;

-
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-

have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charity’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The trustees are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

-

the information given in the trustees' report for the financial year for which the financial statements are prepared, which includes the directors' report prepared for the purposes of company law, is consistent with the financial statements; and

-

the directors' report included within the trustees' report has been prepared in accordance with applicable legal requirements.

NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF NEUROMUSCULAR CENTRE
- 8 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the charity and its environment obtained in the course of the audit, we have not identified material misstatements in the directors' report included within the trustees' report.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

-

adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

-

the financial statements are not in agreement with the accounting records and returns; or

-
certain disclosures of trustees' remuneration specified by law are not made; or
-

we have not received all the information and explanations we require for our audit; or

-

the trustees were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemptions in preparing the trustees' report and from the requirement to prepare a strategic report.

Responsibilities of trustees

As explained more fully in the statement of trustees' responsibilities, the trustees, who are also the directors of the charity for the purpose of company law, are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the trustees are responsible for assessing the charity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF NEUROMUSCULAR CENTRE
- 9 -

We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

To address the risk of fraud through management bias and override of controls, we:

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Other matters

This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Louise Casey ACA (Senior Statutory Auditor)
for and on behalf of BWM
31 August 2024
Chartered Accountants
Statutory Auditor
Suite 5.1
12 Tithebarn Street
Liverpool
L2 2DT
NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
STATEMENT OF FINANCIAL ACTIVITIES
INCLUDING INCOME AND EXPENDITURE ACCOUNT
FOR THE YEAR ENDED 31 MARCH 2024
- 10 -
Current financial year
Unrestricted
Restricted
Total
Total
funds
funds
2024
2024
2024
2023
Notes
£
£
£
£
Income from:
Donations and legacies
3
358,420
35,617
394,037
510,265
Charitable activities
5
715,156
-
715,156
585,132

Fundraising events

4
72,697
-
72,697
62,525
Investments
6
8,426
-
8,426
2,107
Other income
7
315
-
315
148
Total income
1,155,014
35,617
1,190,631
1,160,177
Expenditure on:
Raising funds
8
155,671
-
155,671
145,157
Charitable activities
9
916,809
34,930
951,739
976,191
Total expenditure
1,072,480
34,930
1,107,410
1,121,348
Net movement in funds
82,534
687
83,221
38,829
Reconciliation of funds
Fund balances at 1 April 2023
1,272,631
11,150
1,283,781
1,244,952
Fund balances at 31 March 2024
1,355,165
11,837
1,367,002
1,283,781

The statement of financial activities includes all gains and losses recognised in the year.

All income and expenditure derive from continuing activities.

The movement in funds detailed above complies with the requirements for a statement of changes in equity under FRS102.
The statement of financial activities also complies with the requirements for an income and expenditure account under the Companies Act 2006.
NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
STATEMENT OF FINANCIAL ACTIVITIES (CONTINUED)
INCLUDING INCOME AND EXPENDITURE ACCOUNT
FOR THE YEAR ENDED 31 MARCH 2024
- 11 -
Prior financial year
Unrestricted
Restricted
Total
funds
funds
2023
2023
2023
Notes
£
£
£
Income from:
Donations and legacies
3
313,740
196,525
510,265
Charitable activities
5
585,132
-
585,132

Fundraising events

4
62,525
-
62,525
Investments
6
2,107
-
2,107
Other income
7
148
-
148
Total income
963,652
196,525
1,160,177
Expenditure on:
Raising funds
8
145,157
-
145,157
Charitable activities
9
784,511
191,680
976,191
Total expenditure
929,668
191,680
1,121,348
Net movement in funds
33,984
4,845
38,829
Reconciliation of funds
Fund balances at 1 April 2023
1,238,647
6,305
1,244,952
Fund balances at 31 March 2023
1,272,631
11,150
1,283,781

The statement of financial activities includes all gains and losses recognised in the year.

All income and expenditure derive from continuing activities.

The movement in funds detailed above complies with the requirements for a statement of changes in equity under FRS102.
The statement of financial activities also complies with the requirements for an income and expenditure account under the Companies Act 2006.
NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
BALANCE SHEET
AS AT
31 MARCH 2024
31 March 2024
- 12 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
14
712,408
727,538
Investments
15
9
9
712,417
727,547
Current assets
Debtors
18
149,349
179,277
Cash at bank and in hand
587,222
529,824
736,571
709,101
Liabilities:
Creditors: amounts falling due within one year
19
(81,986)
(152,867)
Net current assets
654,585
556,234
Total net assets
1,367,002
1,283,781
The funds of the charity:
Restricted funds
22
11,837
11,150
Unrestricted funds
Designated funds
23
40,000
-
Unrestricted funds represented by fixed assets
712,417
727,547
Free reserves
602,748
545,084
General unrestricted funds
1,355,165
1,272,631
Total unrestricted funds
1,355,165
1,272,631
Total charity funds
1,367,002
1,283,781

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the trustees and authorised for issue on
22 August 2024
22 August 2024
and are signed on its behalf by:
W Duckworth (Chair)
Trustee
Company Registration No. 2806607
NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 MARCH 2024
- 13 -
2024
2023
Notes
£
£
£
£
Cash flows from operating activities
Net cash provided by operating activities
29
57,355
84,129
Cash flows from investing activities
Purchase of tangible fixed assets
(8,380)
(94,264)
Interest received
8,426
2,107
Net cash generated from/(used in) investing activities
46
(92,157)
Net increase/(decrease) in cash and cash equivalents
57,401
(8,028)
Cash and cash equivalents at beginning of year
529,824
537,853
Cash and cash equivalents at end of year
587,222
529,824
NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
NOTES TO THE  FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
- 14 -
1
Accounting policies
Charity information

The NeuroMuscular Centre is a private company limited by guarantee incorporated in England and Wales and a charity registered with the Charity Commission for England and Wales. The registered office is Woodford Lane West, Winsford, Cheshire, CW7 4EH.

1.1
Accounting convention

The financial statements have been prepared in accordance with the charity's Memorandum and Articles of Association, the Companies Act 2006, FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019). The charity is a Public Benefit Entity as defined by FRS 102.

The accounts are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.

The accounts have been prepared on the historical cost convention. The principal accounting policies adopted are set out below.

The financial statements do not incorporate the results, assets and liabilities of the charity's wholly owned subsidiary, NMC Trading Limited. Consolidated accounts have not been prepared as these would not be materially different from the single entity financial statements as presented. The subsidiary ceased to trade on 1 April 2012 and has remained dormant throughout the period.

1.2
Going concern

At the time of approving the accounts the Trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus, the Trustees continue to adopt the ‘going concern’ basis of accounting in preparing the accounts.

1.3
Charitable funds

Funds held by the charity are:

 

Unrestricted general funds - these are funds which can be used in accordance with the charitable objects at the discretion of the trustees, with due regard to the reserves policy as described in the Trustees' Report.

 

Designated funds - these are funds set aside by the trustees out of unrestricted general funds for specific future purposes.

 

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the charity for particular purposes. The aim and use of each restricted fund is set out in the notes to the financial statements.

NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
1
Accounting policies
(Continued)
- 15 -
1.4
Income

All income is included in the Statement of Financial Activities when the charity is legally entitled to the income and the amount can be quantified with reasonable accuracy.

 

Income from donations and grants, including capital grants, is included in income when these are receivable, except as follows:

 

 

 

Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset.

 

Income is deferred only when the charity has to fulfil conditions before becoming entitled to it or where the donor has specified that the income is to be expended in a future period.

 

When donors specify that donations and grants, including capital grants, are for particular restricted purposes, which do not amount to preconditions regarding entitlement, this income is included as restricted funds when receivable.

 

Voluntary income includes discretionary grants for projects, goods and services where no service agreement or contract exists.

 

Other grants, which have particular service requirements and which are provided in accordance with a contract or service level agreement are included in the Statement of Financial Activities under the heading Charitable Activities.

 

Interest is included when receivable by the charity.

1.5
Expenditure

Expenditure reflects all amounts paid and accrued during the year. Expenditure includes any VAT which cannot be fully recovered, and is reported as part of the expenditure to which it relates. All costs are allocated between the expenditure categories of the Statement of Financial Activities (SOFA) on a basis designed to reflect the use of the resource.

 

Raising funds

These represent costs incurred in seeking voluntary contributions and do not include the costs of disseminating information in support of the charitable activities.

 

Charitable expenditure

Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and services for its beneficiaries. It includes both costs that can be allocated directly to such activities and those costs of an indirect nature necessary to support them. Support costs are allocated across the activities on the basis of expenditure incurred for each of the activities.

 

Governance costs

These represent costs associated with meeting the constitutional and statutory requirements of the charity and include the audit fees and costs linked to the strategic management of the charity.

NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
1
Accounting policies
(Continued)
- 16 -
1.6
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Individual fixed assets costing £1,000 or more are capitalised at cost, including any expenses of acquisition.

 

Depreciation is provided at rates calculated to write off the cost less estimated residual value of each asset over its expected useful life, as follows:

Short leasehold property
Straight line basis over the life of the lease
Fixtures, fittings & equipment
Straight line over 4 - 5 years

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.

1.7
Fixed asset investments

Fixed asset investments are stated at cost less provision for diminution in value.

1.8
Impairment of fixed assets

At each reporting end date, the charity reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

1.9
Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts.

1.10
Financial instruments

The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
1
Accounting policies
(Continued)
- 17 -
Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the charity’s contractual obligations expire or are discharged or cancelled.

1.11
Employee benefits

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received, if material.

 

Termination benefits are recognised immediately as an expense when the charity is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

The charity offers defined contribution pension arrangements to an employers’ portable scheme. Contributions are charged in the financial statements as incurred.

1.13

Taxation

The charity benefits from various exemptions from taxation afforded by tax legislation and is not liable to corporation tax on income or gains falling within those exemptions. Recovery is made of tax deducted from qualifying income and from receipts under Gift Aid.

 

The charity is also able to partially recover Value Added Tax. Expenditure that is not recoverable by the charity is recorded in the accounts inclusive of VAT.

2
Critical accounting estimates and judgements

In the application of the charity’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

 

There are no critical accounting estimates or judgments included in these accounts.

NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 18 -
3
Donations and legacies
Unrestricted
Restricted
Total
Unrestricted
Restricted
Total
funds
funds
funds
funds
Restated
2024
2024
2024
2023
2023
2023
£
£
£
£
£
£
Donations and gifts
299,859
35,617
335,476
313,740
196,525
510,265
Legacies receivable
58,561
-
58,561
-
-
-
358,420
35,617
394,037
313,740
196,525
510,265
Donations and gifts
Community donations
157,979
-
157,979
157,159
-
157,159
Trust and corporate donations
141,880
35,617
177,497
156,581
196,525
353,106
299,859
35,617
335,476
313,740
196,525
510,265
4

Fundraising events

Unrestricted
Unrestricted
funds
funds
2024
2023
£
£
Fundraising events
72,697
62,525
NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 19 -
5
Charitable activities
Unrestricted
Unrestricted
Unrestricted
Unrestricted
funds
funds
funds
funds
Physiotherapy
Supporting employment
Total
2024
Total
2023
£
£
£
£

Income within charitable activities

613,533
101,623
715,156
585,132
For the year ended 31 March 2023
Physiotherapy
Supporting employment
Total
£
£
£

Income within charitable activities

489,106
96,026
585,132
Analysis by fund
Unrestricted funds
489,106
96,026
585,132
6
Investments
Unrestricted
Unrestricted
funds
funds
2024
2023
£
£
Interest receivable
8,426
2,107
7
Other income
Unrestricted
Unrestricted
funds
funds
2024
2023
£
£

Other income

315
148

Other income relates to a Feed-in Tariff (FIT) payment received from the charity's energy provider.

NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 20 -
8
Raising funds
Unrestricted
Unrestricted
funds
funds
2024
2023
£
£

Costs of generating donations and legacies and events

Promotion

59,543
57,653
Staff costs
86,244
84,477
Share of support costs (see note 10)
9,884
3,027
155,671
145,157
NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 21 -
9
Charitable activities
Physiotherapy
Advocacy and care support
Supporting employment
Training
Total
2024
Total
2023
£
£
£
£
£
£
Staff costs
195,690
80,392
65,374
15,161
356,617
410,753
Share of support costs (see note 10)
55,185
371,660
111,622
42,167
580,634
553,286
Share of governance costs (see note 10)
3,622
3,622
3,622
3,622
14,488
12,152
254,497
455,674
180,618
60,950
951,739
976,191
Analysis by fund
Unrestricted funds
254,497
420,744
180,618
60,950
916,809
Restricted funds
-
34,930
-
-
34,930
254,497
455,674
180,618
60,950
951,739
For the year ended 31 March 2023
Physiotherapy
Advocacy and care support
Supporting employment
Training
Total
£
£
£
£
£
Staff costs
283,329
76,432
36,466
14,526
410,753
Share of support costs (see note 10)
86,762
323,198
114,399
28,927
553,286
Share of governance costs (see note 10)
3,038
3,038
3,038
3,038
12,152
373,129
402,668
153,903
46,491
976,191
Analysis by fund
Unrestricted funds
325,693
258,424
153,903
46,491
784,511
Restricted funds
47,436
144,244
-
-
191,680
373,129
402,668
153,903
46,491
976,191
NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 22 -
10
Support costs
Support costs
Governance costs
2024
Support costs
Governance costs
2023
£
£
£
£
£
£
Staff costs
288,507
-
288,507
242,558
-
242,558
Depreciation
23,513
-
23,513
23,999
-
23,999

Utilities and communications

23,652
-
23,652
30,527
-
30,527

Travel

23,900
-
23,900
23,325
-
23,325

Printing

82,652
-
82,652
82,451
-
82,451

Maintenance

47,742
-
47,742
43,297
-
43,297

Insurance and general expenses

100,552
-
100,552
110,156
-
110,156
Audit fees
-
4,250
4,250
-
4,030
4,030
Accountancy
-
4,220
4,220
-
2,270
2,270
Legal and professional
-
6,018
6,018
-
5,852
5,852
590,518
14,488
605,006
556,313
12,152
568,465
Analysed between
Fundraising
9,884
-
9,884
3,027
-
3,027
Charitable activities
580,634
14,488
595,122
553,286
12,152
565,438
590,518
14,488
605,006
556,313
12,152
568,465

Support costs are allocated on the basis of time spent/usage.

Governance costs are split equally between activities.

11
Trustees

None of the trustees (or any persons connected with them) received any remuneration during the year (2023: £nil) and no trustees were reimbursed expenses (2023: none).

12
Auditor's remuneration

The analysis of auditor's remuneration is as follows:

2024
2023
£
£
Fees payable to the company's auditor for the audit of the company's annual accounts
4,250
4,030
All other non-audit services
4,220
2,270
NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 23 -
13
Employees
Number of employees

The average monthly number of employees during the year was:

2024
2023
Number
Number
Charitable activities
26
28
Fundraising
3
3
Administration
1
1
30
32
Employment costs
2024
2023
£
£
Wages and salaries
636,781
627,138
Social security costs
38,185
47,291
Other pension costs
56,402
63,359
731,368
737,788

Redundancy payments of £nil (2023: £17,130) were paid in the year.

There were no employees whose annual remuneration was £60,000 or more (2023: none).
14
Tangible fixed assets
Short leasehold property
Fixtures, fittings & equipment
Total
£
£
£
Cost
At 1 April 2023
1,100,225
277,509
1,377,734
Additions
-
8,380
8,380
At 31 March 2024
1,100,225
285,889
1,386,114
Depreciation
At 1 April 2023
394,498
255,698
650,196
Depreciation charged in the year
14,145
9,365
23,510
At 31 March 2024
408,643
265,063
673,706
Carrying amount
At 31 March 2024
691,582
20,826
712,408
At 31 March 2023
705,727
21,811
727,538

All tangible assets are used in functions of the charity and are shown at written down cost. All material assets are used for direct charitable activities. The leasehold land and buildings are subject to a lease that has recently been renewed and will expire in August 2077.

NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 24 -
15
Fixed asset investments
Other investments
Cost or valuation
At 1 April 2023 & 31 March 2024
9
Carrying amount
At 31 March 2024
9
At 31 March 2023
9
2024
2023
Other investments comprise:
Notes
£
£
Investments in subsidiaries
16
9
9

 

16
Subsidiaries

Details of the charity's subsidiary at 31 March 2024 are as follows:

Name of undertaking and country of
Nature of business
Class of
% Held
incorporation or residency
shareholding
Direct
Indirect
NMC Trading Limited
England and Wales
Dormant
Ordinary
100.00
-
The aggregate capital and reserves and the result for the year of subsidiaries excluded from consolidation was as follows:
Name of undertaking
Profit/(Loss)
Capital and Reserves
£
£
NMC Trading Limited
-
9
NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 25 -
17
Financial instruments
2024
2023
£
£
Carrying amount of financial assets
Debt instruments measured at cost
708,131
676,692
Equity instruments measured at cost
9
9
708,140
676,701
Carrying amount of financial liabilities
Measured at cost
13,315
23,210
18
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
80,909
143,631
Other debtors
45,693
10,673
Prepayments and accrued income
22,747
24,973
149,349
179,277
19
Creditors: amounts falling due within one year
2024
2023
Notes
£
£
Other taxation and social security
11,208
11,842
Deferred income
20
57,463
117,815
Trade creditors
6,006
16,871
Amounts due to subsidiary undertakings
9
9
Accruals
7,300
6,330
81,986
152,867
NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 26 -
20
Deferred income
2024
2023
£
£
Other deferred income
57,463
117,815
57,463
117,815

Deferred income is included in the financial statements as follows:

2024
2023
£
£
Total deferred income at 1 April 2023
117,815
66,336
Amounts received in year
57,463
117,815
Amounts credited to statement of financial activities
(117,815)
(66,336)
57,463
117,815
21
Retirement benefit schemes
Defined contribution schemes

The charity operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the charity in an independently administered fund.

The charge to the statement of financial activities in respect of defined contribution schemes was £56,402 (2023: £63,359).

NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 27 -
22
Restricted funds
The income funds of the charity include restricted funds comprising the following unexpended balances of donations and grants held on trust for specific purposes:
Movement in funds
Movement in funds
Balance at
1 April 2022

Income

Expenditure

Balance at
1 April 2023

Income

Expenditure

Balance at
31 March 2024
£
£
£
£
£
£
£
Physiotherapy fund
5,585
41,851
(47,436)
-
-
-
-
Support worker fund
720
26,056
(26,776)
-
30,647
(25,273)
5,374
Transition and development
-
69,618
(58,468)
11,150
4,970
(9,657)
6,463
Bathroom project
-
59,000
(59,000)
-
-
-
-
6,305
196,525
(191,680)
11,150
35,617
(34,930)
11,837

Physiotherapy fund - a core service of the NMC, this fund ensures the department has modern equipment with which to provide innovative and specialist treatments.

 

Support worker fund - this role provides a range of services including equipment and adaptation advice, guidance on benefits and work assistance, and emotional support in times of need.

 

Transition & Development Fund – meeting the growing demand from younger people, NMC now provides services to support them into adulthood, with independence, work readiness and personal growth being key aims.

 

The Bathroom project renovated the Centre's toilets and showers, replacing 25 year old facilities with the latest, state of the art equipment to provide maximum comfort for our visitors and inspiration for members of our community who may need to adapt their homes as a consequence of their condition.

 

 

NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 28 -
23
Designated funds
The income funds of the charity include the following designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes:
Balance at
1 April 2022
Transfers
Balance at
1 April 2023
Transfers
Balance at
31 March 2024
£
£
£
£
£
Car park works
-
-
-
40,000
40,000
-
-
-
40,000
40,000

£40,000 has been designated in the year to fund the costs of resurfacing the Centre's car park which will be done in 2024/25.

24
Capital commitments
2024
2023
£
£

At 31 March 2024 the charity had capital commitments as follows:

Contracted for but not provided in the financial statements:
Acquisition of property, plant and equipment
40,000
-

The above capital commitment relates to work carried out at the Centre car park. This amount has been set aside at the year end as a designated fund, see note 23.

25
Analysis of net assets between funds
Unrestricted funds
Restricted funds
Total
Unrestricted
Restricted funds
Total
2024
2024
2024
2023
2023
2023
£
£
£
£
£
£
Fund balances at 31 March 2024 are represented by:
Tangible assets
712,408
-
712,408
727,538
-
727,538
Investments
9
-
9
9
-
9
Current assets/(liabilities)
642,748
11,837
654,585
545,084
11,150
556,234
1,355,165
11,837
1,367,002
1,272,631
11,150
1,283,781
NEUROMUSCULAR CENTRE
COMPANY LIMITED BY GUARANTEE
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 29 -
26
Operating lease commitments

At the reporting end date the charity had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

2024
2023
£
£
Within one year
598
1,196
Between two and five years
-
598
598
1,794
27
Related party transactions
Remuneration of key management personnel

The remuneration of key management personnel, is as follows.

2024
2023
£
£
Aggregate remuneration
61,969
71,357

As at 31 March 2023, there is a creditor balance owing to the wholly owned subsidiary NMC Trading Limited of £9 (2023: £9).

 

There were no other related party transactions.

No guarantees have been given or received.

28
Company limited by guarantee

The Neuromuscular Centre is incorporated under the Companies Act as a company limited by guarantee. The liability of the members is limited to £1.

29
Cash generated from operations
2024
2023
£
£
Net income for the year (as per the statement of financial activities)
83,221
38,829
Adjustments for:
Investment income recognised in statement of financial activities
(8,426)
(2,107)
Depreciation of tangible fixed assets
23,513
23,999
Movements in working capital:
Decrease/(increase) in debtors
29,928
(39,323)
(Decrease)/increase in creditors
(10,529)
11,252
(Decrease)/increase in deferred income
(60,352)
51,479
Net cash provided by operating activities
57,355
84,129
2024-03-312023-04-01falseCCH SoftwareiXBRL Review & Tag 2022.228066072023-04-012024-03-312806607bus:Director12023-04-012024-03-312806607bus:Director32023-04-012024-03-312806607bus:Director42023-04-012024-03-312806607bus:Director52023-04-012024-03-312806607bus:Director62023-04-012024-03-312806607bus:Director72023-04-012024-03-312806607bus:Director82023-04-012024-03-312806607bus:Director92023-04-012024-03-312806607bus:Director102023-04-012024-03-312806607bus:CompanySecretary12023-04-012024-03-312806607bus:Director22023-04-012024-03-3128066072024-03-3128066072023-03-3128066072022-04-012023-03-312806607bus:FRS1022023-04-012024-03-312806607bus:Audited2023-04-012024-03-312806607bus:FullAccounts2023-04-012024-03-31xbrli:purexbrli:sharesiso4217:GBP